全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
Health  2019 

An Analysis of the Effects of Blood Pressure and Antihypertensive Drugs on Heart Disease

DOI: 10.4236/health.2019.116064, PP. 792-816

Keywords: Heart Disease, 2017 ACC/AHA Hypertension Guideline, Hypertension, Blood Pressure, Antihypertensive Drug, Diabetes

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background: The American College of Cardiology (ACC), American Heart Association (AHA) and other organizations announced a new hypertension guideline (2017 ACA/AHA Guideline) in November 2017. However, other organizations such as the European Society of Cardiology and European Society of Hypertension maintained their diagnostic thresholds. It is necessary to evaluate the effects of blood pressure (BP) and antihypertensive drugs on the probability of having heart disease (HD). Data and Methods: The effects of BP, antihypertensive drugs and other factors on the probability of undergoing HD treatment were analyzed. We used a dataset containing 83,287 medical check-up and treatment records obtained from 35,504 individuals in 5 fiscal years. The probit models were used in the study. Considering the possibility of endogeneity problems, different types of models were used. Results: We could not find evidence that a higher systolic BP increased the probability of undergoing HD treatment. However, diastolic BP increased the probability in most of the models. Taking antihypertensive drugs also increased the probability of undergoing HD treatment. Diabetes was another important risk factor. Conclusion: The results of this study did not support the new 2017 ACC/AHA Guideline. It is necessary to choose proper drugs and methods to reduce the risks of side effects. Limitations: The dataset was observatory, the data were obtained from just one medical society, and sample selection bias might exist.

References

[1]  World Health Organization (WHO) (2019) Raised Blood Pressure.
https://www.who.int/gho/ncd/risk_factors/blood_pressure_prevalence_text/en/
[2]  WHO and International Society of Hypertension Writing Group (2003) 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) Statement on Management of Hypertension. Journal of Hypertension, 11, 1983-1992.
https://doi.org/10.1097/00004872-200311000-00002
[3]  Gaziano, T.A., Bitton, A., Anand, S. and Weinstein, M. (2009) The Global Cost of Nonoptimal Blood Pressure. Journal of Hypertension, 27, 1472-1477.
https://doi.org/10.1097/HJH.0b013e32832a9ba3
[4]  Benjamin, E.J., Blaha, M.J., Chiuve, S.E., et al. (2017) Heart Disease and Stroke Statistics—2017 Updates: A Report from the American Heart Association. Circulation, 135, e146-e603.
https://doi.org/10.1161/CIR.0000000000000491
[5]  Wang, G., Grosse, G.S.D. and Schooley, M.W. (2017) Conducting Research on the Economics of Hypertension to Improve Cardiovascular Health. American Journal of Preventive Medicine, 53, S115-S117.
https://doi.org/10.1016/j.amepre.2017.08.005
[6]  Centers for Disease Control and Prevention (2016) High Blood Pressure Fact Sheet.
https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_bloodpressure.htm
[7]  Ministry of Health, Welfare, and Labor (2018) Heisei 28 nendo kokumin iryouhi no gayou (Summary of National Medical Expenditures, Fiscal Year 2016) (in Japanese).
[8]  Blanchflower, D.G. and Oswald, A.J. (2008) Hypertension and Happiness across Nations. Journal of Health Economics, 27, 218-233.
https://doi.org/10.1016/j.jhealeco.2007.06.002
[9]  Mojon-Azzi, S. and Sousa-Pazo, A. (2011) Hypertension and Life Satisfaction: An Analysis Using Data from the Survey of Health, Aging and Retirement in Europe. Applied Economics Letters, 18, 183-187.
https://doi.org/10.1080/13504850903508291
[10]  Japanese Society of Hypertension (2014) Guidelines for the Management of Hypertension 2014. (In Japanese)
http://www.jpnsh.jp/data/jsh2014/jsh2014v1_1.pdf
[11]  Blood Pressure Association (2008) Blood Pressure Chart for Adults.
http://www.bloodpressureuk.org/BloodPressureandyou/Thebasics/Bloodpressurechart
[12]  National Heart, Lung and Blood Institute, US Department of Health & Human Services (2015) Description of High Blood Pressure.
https://www.nhlbi.nih.gov/
[13]  Guidelines Subcommittee (1999) 1999 World Health Organization—International Society of Hypertension Guidelines for Management of Hypertension. Journal of Hypertension, 17, 151-183.
https://doi.org/10.1097/00004872-199917020-00001
[14]  Whelton, P.K., Carey, R.M., Arrow, W.S., et al. (2018) 2017 ACC/AHA/AAPA/ ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension, 71, e13-e115.
https://doi.org/10.1161/HYP.0000000000000076
[15]  Whelton, P.K., Carey, R.M., Arrow, W.S., et al. (2018) 2017 Guideline for Blood Pressure in Adults. American College of Cardiology.
http://www.acc.org/latest-in-cardiology/ten-points-to-remember/2017/11/09/11/41/2017-guideline-for-high-blood-pressure-in-adults
[16]  Carey, R.M. and Whelton, P.K. (2018) Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline. Annals of Internal Medicine, 168, 351-335.
https://doi.org/10.7326/M17-3203
[17]  Levine, G.N., O’Gara, P.T., Beckman, J.A., et al. (2019) Modifications, and Evolution of ACC/AHA Clinical Practice Guidelines: An Update for Our Constituencies. Journal of the American College of Cardiology, 73, 1990-1998.
https://doi.org/10.1016/j.jacc.2019.02.012
[18]  Chobanian, A.V., Bakris, G.L., Black, H.B., et al. (2003) Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, 42, 1206-1252.
https://doi.org/10.1161/01.HYP.0000107251.49515.c2
[19]  National Heart, Lung, and Blood Institute, U.S. Department of Health and Human Services (2004) National High Blood Pressure Education Program: Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (Complete Report).
https://www.nhlbi.nih.gov/files/docs/guidelines/jnc7full.pdf
[20]  Khera, R., et al. (2018) Impact of 2017 ACC/AHA Guidelines on Prevalence of Hypertension and Eligibility for Antihypertensive Treatment in United States and China: Nationally Representative Cross Sectional Study. The British Medical Journal, 362, k2357.
https://doi.org/10.1136/bmj.k2357
[21]  Chuang, S.Y., Chang, H.Y., Cheng, H.M., Pan, W.-H. and Chen, C.-H. (2019) Impacts of the New 2017 ACC/AHA Hypertension Guideline on the Prevalence of Brachial Hypertension and Its Concordance with Central Hypertension. American Journal of Hypertension, 32, 409-417.
https://doi.org/10.1093/ajh/hpz008
[22]  Marchesan, L.B. and Spritzer, P.M. (2019) ACC/AHA 2017 Definition of High Blood Pressure: Implications for Women with Polycystic Ovary Syndrome. Fertility and Sterility, 111, 579-587.
https://doi.org/10.1016/j.fertnstert.2018.11.034
[23]  Williams, B., Mancia, G., Spiering, W., et al. (2018) 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension. European Heart Journal, 39, 3021-3104.
[24]  Nerenberg, K.A., Zarnke, K.B., Leung, A.A., et al. (2018) Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. Canadian Journal of Cardiology, 34, 506-525.
[25]  Goupil, R., Lamarre-Cliche, M. and Vallée, M. (2018) The 2017 American College of Cardiology/American Heart Association vs Hypertension Canada High Blood Pressure Guidelines and Potential Implications. Canadian Journal of Cardiology, 34, 665-669.
https://doi.org/10.1016/j.cjca.2018.01.011
[26]  American Diabetes Association (2018) Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2018. Diabetes Care, 41, S86-S104.
https://doi.org/10.2337/dc18-S009
[27]  Hirawa, N., Umemura, S. and Ito, S. (2019) Viewpoint on Guidelines for Treatment of Hypertension in Japan. Circulation Research, 124, 981-983.
https://doi.org/10.1161/CIRCRESAHA.119.314991
[28]  American Academy of Family Physicians (AAFP) (2017) AAFP Decides to Not Endorse AHA/ACC Hypertension Guideline, Academy Continues to Endorse JNC8 Guideline. AAFP News.
https://www.aafp.org/news/health-of-the-public/20171212notendorseaha-accgdlne.html
[29]  Wright, J.T., Williamson, J.D., Whelton, P.K., et al. (2015) A Randomized Trial of Intensive versus Standard Blood-Pressure Control. The New England Journal of Medicine, 373, 2103-2116.
https://doi.org/10.1056/NEJMoa1511939
[30]  Boston University and the National Heart, Lung, & Blood Institute (2019) Framingham Heart Study.
https://www.framinghamheartstudy.org/
[31]  Harvard Health Publishing (2017) The Power of the Placebo Effect. Harvard Medical School.
https://www.health.harvard.edu/mental-health/the-power-of-the-placebo-effect
[32]  Hoenemeyer, T.W., Kaptchuk, T.J., Mehta, T.S. and Fontaine, K.R. (2018) Open-Label Placebo Treatment for Cancer-Related Fatigue: A Randomized-Controlled Clinical Trial. Scientific Reports, 8, Article No. 2784.
https://doi.org/10.1038/s41598-018-20993-y
[33]  Leung, A.A., Chang, H.J., McAlister, F.A., et al. (2018) Applicability of the Systolic Blood Pressure Intervention Trial (SPRINT) to the Canadian Population. Canadian Journal of Cardiology, 34, 670-675.
https://doi.org/10.1016/j.cjca.2018.01.008
[34]  ACCORD Study Group (2010) Effect of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus. The New England Journal of Medicine, 362, 1575-1585.
https://doi.org/10.1056/NEJMoa1001286
[35]  Prospective Studies Collaboration (2002) Age-Specific Relevance of Usual Blood Pressure to Vascular Mortality: A Meta-analysis of Individual Data for One Million Adults in 61 Prospective Studies. The Lancet, 360, 1903-1913.
https://doi.org/10.1016/S0140-6736(02)11911-8
[36]  Ettehad, D., Emdin, C.A., et al. (2016) Blood Pressure Lowering for Prevention of Cardiovascular Disease and Death: A Systematic Review and Meta-Analysis. The Lancet, 387, 957-967.
https://doi.org/10.1016/S0140-6736(15)01225-8
[37]  Joffres, M.R., Mamet, P., MacLean, D.R., L’italien, G.J. and Fodor, G. (2001) Distribution of Blood Pressure and Hypertension in Canada and the United States. American. Journal of Hypertension, 14, 1099-1105.
https://doi.org/10.1016/S0895-7061(01)02211-7
[38]  Rapsomaniki, E., Timmis, A., George, J., et al. (2014) Blood Pressure and Incidence of Twelve Cardiovascular Diseases: Lifetime Risks, Healthy Life-Years Lost, and Age-Specific Associations in 1.25 Million People. The Lancet, 383, 1899-1911.
https://doi.org/10.1016/S0140-6736(14)60685-1
[39]  Muntner, P., Carey, R.M., Gidding, S., et al. (2018) Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline. Journal of the American College of Cardiology, 71, 109-118.
https://doi.org/10.1016/j.jacc.2017.10.073
[40]  Ihm, S.H., Bakris, G., Sakuma, I., et al. (2019) Controversies in the 2017 ACC/AHA Hypertension Guidelines: Who Can Be Eligible for Treatments under the New Guidelines?—An Asian Perspective. Circulation Journal, 83, 504-510.
[41]  Department of Public Health, Shiga University of Medical Science (2018) NIPPON DATA 2010. (In Japanese)
https://hs-web.shiga-med.ac.jp/Nippondata/NIPPONDATA2010/
[42]  Miura, K., Nagai, M. and Ohkubo, T. (2013) Epidemiology of Hypertension in Japan—Where Are We Now? Circulation Journal, 77, 2226-2231.
[43]  Fujiyoshi, A., Ohkubo, T., Miura, K., et al. (2012) Blood Pressure Categories and Log-Term Risk of Cardiovascular Disease According to Age Group in Japanese Men and Women. Hypertension Research, 35, 947-953.
https://www.nature.com/articles/hr201287
https://doi.org/10.1038/hr.2012.87
[44]  Asayama, K., Satoh, M., Murakami, Y., et al. (2014) Cardiovascular Risk With and Without Antihypertensive Drug Treatment in the Japanese General Population Participant-Level Meta-Analysis. Hypertension, 63, 1189-1197.
https://doi.org/10.1161/HYPERTENSIONAHA.113.03206
[45]  Department of Epidemiology and Public Health, Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University (2018) Kugayama Kenkyu (Kugayama Study). (In Japanese)
http://www.hisayama.med.kyushu-u.ac.jp/about/index.html
[46]  Honda, T., Yoshida, D., Hata, J., et al. (2018) Development and Validation of Modified Risk Prediction Models for Cardiovascular Disease and Its Subtypes: The Hisayama Study. Atherosclerosis, 279, 38-44.
https://doi.org/10.1016/j.atherosclerosis.2018.10.014
[47]  Nawata, K., Sekizawa, Y. and Kimura, M. (2018) Evaluation of Blood Pressure Control Medicines Using Health and Medical Checkup Data in Japan: Alternative Methods for Randomized Controlled Trials. Health, 10, 587-603.
https://doi.org/10.4236/health.2018.105047
[48]  Nawata, K., Matsumoto, A., Kajihara, K. and Kimura, M. (2017) Evaluation of the Distribution of and Factors Affecting Blood Pressure Using Medical Checkup Data in Japan. Health, 9, 124-137.
https://doi.org/10.4236/health.2017.91009
[49]  Nawata, K. and Kimura, M. (2018) Empirical Studies of Effects of High Blood Pressure on Medical Costs and Heart Disease: Is the 2017 ACC/AHA Guideline Supported by Enough Evidence? Health, 10, 1498-1519.
https://doi.org/10.4236/health.2018.1011115
[50]  Nawata, K. and Kimura, M. (2018) Does High Systolic Blood Pressure Truly Increase Medical Expenditure? An Empirical Analysis of the New 2017 ACC/AHA Hypertension Guideline. Health, 10, 1044-1065.
https://doi.org/10.4236/health.2018.108079
[51]  Japanese Law Translation (2009) Industrial Safety and Health Act.
http://www.japaneselawtranslation.go.jp/law/detail/?id=1926&vm=&re
[52]  Ministry of Health Labour and Welfare (2016) Diseases of the Circulatory System.
https://www.mhlw.go.jp/toukei/sippei/dl/naiyou09.pdf
[53]  World Health Organization (2019) ICD-10 Online Versions.
https://www.who.int/classifications/icd/icdonlineversions/en/
[54]  Cox, D.R. (1972) Regression Models and Life-Tables. Journal of the Royal Statistical Society: Series B (Methodological), 34, 187-202.
https://doi.org/10.1111/j.2517-6161.1972.tb00899.x
[55]  American Heart Association (AHA) (2017) About Cholesterol.
http://www.heart.org/HEARTORG/Conditions/Cholesterol/AboutCholesterol/About-Cholesterol_UCM_001220_Article.jsp#.Wtrw2ojFKUk
[56]  WHO (2018) Raised Cholesterol.
http://www.who.int/gho/ncd/risk_factors/cholesterol_text/en/
[57]  Centers for Disease Control and Prevention (2017) LDL and HDL Cholesterol: “Bad” and “Good” Cholesterol.
https://www.cdc.gov/cholesterol/ldl_hdl.htm
[58]  American Heart Association (2017) HDL (Good), LDL (Bad) Cholesterol and Triglycerides.
https://www.heart.org/en/health-topics/cholesterol/hdl-good-ldl-bad-cholesterol-and-triglycerides
[59]  U.S. National Library of Medicine (2018) Medical Encyclopedia.
https://medlineplus.gov/encyclopedia.html
[60]  Medline Plus (2018) High Blood Pressure Medicines. U.S. National Library of Medicine
https://medlineplus.gov/ency/article/007484.htm
[61]  The Japanese Society of Hypertension (2014) Guidelines for the Management of Hypertension 2014. (In Japanese)
http://www.jpnsh.jp/data/jsh2014/jsh2014v1_1.pdf
[62]  Laurent, S. (2017) Antihypertensive Drugs. Pharmacological Research, 124, 116-125.
https://doi.org/10.1016/j.phrs.2017.07.026
[63]  WebMed (2018) Side Effects of High Blood Pressure Medications.
https://www.webmd.com/hypertension-high-blood-pressure/guide/side-effects-high-blood-pressure-medications#1
[64]  Kario, K., Thijs, L. and Staessen, J.A. (2019) Blood Pressure Measurement and Treatment Decisions, Masked and White-Coat Hypertension. Circulation Research, 124, 990-1008.
https://doi.org/10.1161/CIRCRESAHA.118.313219
[65]  Harvard Heath Publishing (2017) Controlling Blood Pressure with Fewer Side Effects. Harvard Medical School.
https://www.health.harvard.edu/heart-health/controlling-blood-pressure-with-fewer-side-effects

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133